Results 71 to 80 of about 9,856 (174)

Unlocking the therapeutic potential of the NKG2A-HLA-E immune checkpoint pathway in T cells and NK cells for cancer immunotherapy

open access: yesJournal for ImmunoTherapy of Cancer
Immune checkpoint blockade, which enhances the reactivity of T cells to eliminate cancer cells, has emerged as a potent strategy in cancer therapy. Besides T cells, natural killer (NK) cells also play an indispensable role in tumor surveillance and ...
Yan Li   +8 more
doaj   +1 more source

NKG2A and the functional competence of liver natural killer cells

open access: yesThe FASEB Journal, 2008
The liver is a unique environment that maintains tolerance to a heavy load of foreign antigens derived from the intestine. The liver is also the site of several chronic viral infections, including hepatitis B & C viruses.
Matthew G. Lassen, Young S. Hahn
openaire   +1 more source

Safety and Feasibility of Blockade of NK Group-2 Member-A Receptor in Natural Killer Cells Combined with Cetuximab Antibody in Patients with Advanced Gastric Adenocarcinoma [PDF]

open access: yesAdvanced Pharmaceutical Bulletin
Purpose: Blocking of inhibitory receptors such as NK group-2 member-A (NKG2A) enhances tumor immunity of natural killer (NK) cells. Additionally, antibody-dependent cellular cytotoxicity (ADCC) is an important cytotoxic modality of action of NK cells ...
Maryam Samareh-Salavatipour   +10 more
doaj   +1 more source

Differential expression of NK receptors CD94 and NKG2A by T cells in rheumatoid arthritis patients in remission compared to active disease.

open access: yesPLoS ONE, 2011
ObjectiveTNF inhibitors (TNFi) have revolutionised the treatment of rheumatoid arthritis (RA). Natural killer (NK) cells and Natural Killer Cell Receptor+ T (NKT) cells comprise important effector lymphocytes whose activity is tightly regulated through ...
Ceara E Walsh   +8 more
doaj   +1 more source

Exploring NK cell receptor dynamics in paediatric leukaemias: implications for immunotherapy and prognosis

open access: yesClinical & Translational Immunology
Objectives Immunotherapies targeting natural killer (NK) cell receptors have shown promise against leukaemia. Unfortunately, cancer immunosuppressive mechanisms that alter NK cell phenotype prevent such approaches from being successful.
Cui Tu   +8 more
doaj   +1 more source

A novel NKG2A alpaca nanobody targeting immune checkpoint blockade for the treatment of malignant melanoma

open access: yesFrontiers in Veterinary Science
Alpacas belong to the Camelidae family. Antibodies produced through alpaca immunization are called nanoantibodies. Compared to traditional antibodies, nanoantibodies have several characteristics, including smaller molecular weight, stable structure, high
Xiang Guo   +10 more
doaj   +1 more source

Increased proliferative response of highly differentiated CD57+NKG2C+NK cells expressing NKG2A

open access: yesМедицинская иммунология
During infection with cytomegalovirus (HCMV), the content of so-called adaptive NK cells with the CD57+NKG2C+ phenotype increases in the peripheral blood, capable of exhibiting specialized functional activity aimed at controlling the infection upon ...
N. A. Alekseeva   +2 more
doaj   +1 more source

Senescent cells evade immune clearance via HLA-E-mediated NK and CD8+ T cell inhibition

open access: yesNature Communications, 2019
Senescent cells increase with ageing and may cause inflammatory conditions, but how this accumulation is mediated is still unclear. Here the authors show that senescent cells express HLA-E to suppress NKG2A-mediated natural killer and CD8 T cell ...
Branca I. Pereira   +15 more
doaj   +1 more source

Torque teno viruses exhaust and imprint the human immune system via the HLA-E/NKG2A axis

open access: yesFrontiers in Immunology
The ubiquitous Torque teno virus (TTV) establishes a chronically persistent infection in the human host. TTV has not been associated with any apparent disease, but, as part of the human virome, it may confer a regulatory imprint on the human immune ...
Hannes Vietzen   +10 more
doaj   +1 more source

Generation, Characterization, and Preclinical Studies of a Novel NKG2A-Targeted Antibody BRY805 for Cancer Immunotherapy

open access: yesAntibodies
Immuno-oncology has revolutionized cancer treatment, with NKG2A emerging as a novel target for immunotherapy. The blockade of NKG2A using the immune checkpoint inhibitor (ICI) monalizumab has been shown to enhance the responses of both NK cells and CD8 ...
Yaqiong Zhou   +13 more
doaj   +1 more source

Home - About - Disclaimer - Privacy